Email Alert | RSS

Journal of Peking University(Health Sciences) ›› 2019, Vol. 51 ›› Issue (2): 234-238. doi: 10.19723/j.issn.1671-167X.2019.02.006

Previous Articles     Next Articles

Rasfonin inhibits proliferation and migration of osteosarcoma 143B cells

Fan ZHANG1,2,Tai-qiang YAN1,∆(),Wei GUO1   

  1. 1. Musculoskeletal Tumor Center, Peking University People’s Hospital, Beijing 100044, China;
    2. Department of Bone and Soft Tissue, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
  • Received:2017-04-12 Online:2019-04-18 Published:2019-04-26
  • Contact: Tai-qiang YAN E-mail:yantqzh@163.com
  • Supported by:
    the National Natural Science Foundation of China(81272381)

RICH HTML

   

PDF (PC)

Abstract:

Objective: To investigate the effects of rasfonin,a fungal secondary metabolite, on the proliferation and migration of osteosarcoma 143B cells.Methods: 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium,inner salt (MTS) assay was performed to exa-mine 143B cell viability following treatment of rasfonin. Using dimethyl sulfoxide (DMSO) group as control, cell viability was detected when 143B cells were treated with rasfonin (3 μmol/L and 6 μmol/L) for 12 or 24 hours. The effect of rasfonin on colony forming ability was detected by clone formation assay.143B cells treated with DMSO or rasfonin (3 μmol/L) for one week, and the number of clones formed in the two groups was counted. Wound healing and transwell assay were employed to analyze cell invasion and migration upon rasfonin challenge. The DMSO group was used as control while rasfonin (3 μmol/L) was used for 24 hours. The wound healing rate and the number of invasive cells were compared between the two groups. The intracellular autophagosomes were monitored by transmission electron microscopy when 143B cells were treated with DMSO or rasfonin (3 μmol/L) for 4 hours. The expression of p62, microtubule-associated protein 1 light chain 3 fusion protein (LC3) and poly (ADP-ribose) polymerase-1(PARP-1) in response to rasfonin were detected by immunoblotting assay.Results: Rasfonin reduced the viability of 143B cells in a dose-dependent manner (12 h: F=31.36, P<0.01; 24 h: F=67.07, P<0.01). Rasfonin (3 μmol/L) completely inhibited the clonal formation of 143B cells (P<0.01). The wound healing result revealed that rasfonin significantly decreased migratory ability of 143B cells (33.91%±0.83% vs. 65.11%±0.94%, P<0.01), whereas its treatment significantly reduced the number of 143B cells penetrating through Matrigel-containing basement membrane (21.33±1.45 vs. 49.33±2.40, P<0.01). Compared with the control group, rasfonin markedly increased the number of autophagic vacuoles. The immunoblotting results revealed that rasfonin increased LC3-Ⅱ accumulation and decreased p62 levels. Choloroquine (CQ), an often used autophagic inhibitor, further accumulated rasfonin-induced LC3-Ⅱ. In addition, rasfonin appeared to cause the cleavage of PARP-1.Conclusion: Rasfonin induced autophagy and activated caspase-dependent apoptosis in 143B cells concurring with suppressing the proliferation and migration of the cells; these results provide an experimental basis for rasfonin as a potential therapeutic agent for osteosarcoma.

Key words: Osteosarcoma, Proliferation, Migration, Autophagy

CLC Number: 

  • R738.1

Figure 1

Rasfonin inhibits cell viability of 143B cells A,143B cells were treated with rasfonin (3 μmol/L and 6 μmol/L) for up to 24 h, cell viability was analyzed by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS)assay;B,colony growth assays were performed in 143B cells with rasfonin (3 μmol/L).*P<0.01, vs.DMSO group.DMSO, dimethyl sulfoxide."

Figure 2

Rasfonin inhibits migratory and invasive abilities of 143B cells A and B, wound healing assay and transwell assay were performed in143B cells in the present of DMSO or rasfonin (3 μmol/L); B, stained with crystal violet, ×100.DMSO, dimethyl sulfoxide."

Figure 3

Rasfonin increases autophagy and apoptosis of 143B cells A,electron microscopy was performed in 143B cells after exposed to rasfonin (3 μmol/L) for 4 h,×9 900; B and C, following treatment of rasfonin (B: 3 μmol/L and 6 μmol/L, C:3 μmol/L) for 4 h with or without Choloroquine (CQ), 143B cells were lysed and analyzed by immunoblotting using the indicated antibodies.Actin was used as a loading control; D, expression of poly (ADP-ribose) polymerase-1(PARP-1) was analyzed by immunoblotting after treated by rasfoninfor 4 h. Actin was used as a loading control.DMSO, dimethyl sulfoxide; CQ,choloroquine;LC3, microtubule associated protein 1 light chain 3 fusion protein; PARP, poly (ADP-ribose) polymerase."

[1] Osasan S, Zhang M, Shen F , et al. Osteogenic sarcoma: a 21st century review[J]. Anticancer Res, 2016,36(9):4391-4398.
doi: 10.21873/anticanres
[2] Shaikh AB, Li F, Li M , et al. Present advances and future perspectives of molecular targeted therapy for osteosarcoma[J]. Int J Mol Sci, 2016,17(4):506.
doi: 10.3390/ijms17040506
[3] Tomikawa T, Shin-Ya K, Furihata K , et al. Rasfonin, a new apoptosis inducer in ras-dependent cells from Talaromyces sp.[J]. J Antibiot (Tokyo), 2000,53(8):848-850.
doi: 10.7164/antibiotics.53.848
[4] Xiao Z, Li L, Li Y , et al. Rasfonin, a novel 2-pyrone derivative, induces ras-mutated Panc-1 pancreatic tumor cell death in nude mice[J]. Cell Death Dis, 2014,5(5):e1241.
doi: 10.1038/cddis.2014.213
[5] Lu Q, Yan S, Sun H , et al. Akt inhibition attenuates rasfonin-induced autophagy and apoptosis through the glycolytic pathway in renal cancer cells[J]. Cell Death Dis, 2015,6(12):e2005.
doi: 10.1038/cddis.2015.344
[6] Ouyang L, Shi Z, Zhao S , et al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis[J]. Cell Prolif, 2012,45(6):487-498.
doi: 10.1111/cpr.2012.45.issue-6
[7] Hale AN, Ledbetter DJ, Gawriluk TR , et al. Autophagy: regulation and role in development[J]. Autophagy, 2013,9(7):951-972.
doi: 10.4161/auto.24273
[8] Levine B, Yuan J . Autophagy in cell death: an innocent convict?[J]. J Clin Invest, 2005,115(10):2679-2688.
doi: 10.1172/JCI26390
[9] Eisenberg-Lerner A, Bialik S, Simon HU , et al. Life and death partners: apoptosis, autophagy and the cross-talk between them[J]. Cell Death Differ, 2009,16(7):966-975.
doi: 10.1038/cdd.2009.33
[10] 燕太强, 梁伟民, 郭卫 . 骨肉瘤的诊疗和研究进展[J]. 中华临床医师杂志: 电子版, 2012(17):4988-4990.
[11] Wang W, Sun H, Che Y , et al. Rasfonin promotes autophagy and apoptosis via upregulation of reactive oxygen species (ros)/jnk pathway[J]. Mycology, 2016,7(2):64.
doi: 10.1080/21501203.2016.1170073
[12] Galluzzi L, Vitale I, Abrams JM , et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012[J]. Cell Death Differ, 2012,19(1):107-120.
doi: 10.1038/cdd.2011.96
[13] Kanzawa T, Germano IM, Komata T , et al. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells[J]. Cell Death Differ, 2004,11(4):448-457.
doi: 10.1038/sj.cdd.4401359
[14] Shinojima N, Yokoyama T, Kondo Y , et al. Roles of the akt/mtor/p70s6k and erk1/2 signaling pathways in curcumin-induced autophagy[J]. Autophagy, 2007,3(6):635-637.
doi: 10.4161/auto.4916
[15] 曹珮, 姜学军, 席志军 . 舒尼替尼通过抑制 Akt/mTOR 信号通路诱导肾癌细胞自噬[J]. 北京大学学报(医学版), 2016,48(4):584-589.
doi: 10.3969/j.issn.1671-167X.2016.04.003
[1] Yao ZHANG,Jinxin GUO,Shijia ZHAN,Enyu HONG,Hui YANG,Anna JIA,Yan CHANG,Yongli GUO,Xuan ZHANG. Role and mechanism of cysteine and glycine-rich protein 2 in the malignant progression of neuroblastoma [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 495-504.
[2] Lei WANG,Tian-dong HAN,Wei-xing JIANG,Jun LI,Dao-xin ZHANG,Ye TIAN. Comparison of safety and effectiveness of active migration technique and in situ lithotripsy technique in the treatment of 1-2 cm upper ureteral calculi by flexible ure-teroscopy [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 553-557.
[3] Li-ye LAI,Chang-song DOU,Cui-na ZHI,Jie CHEN,Xue MA,Peng ZHAO,Bi-yun YAO. Curcumin alleviates the manganese-induced neurotoxicity by promoting autophagy in rat models of manganism [J]. Journal of Peking University (Health Sciences), 2022, 54(3): 400-411.
[4] YANG Duo,ZHOU Xin-na,WANG Shuo,WANG Xiao-li,YUAN Yan-hua,YANG Hua-bin,GENG Hui-zhen,PENG Bing,LI Zi-bo,LI Bin,REN Jun. Assessment of lymphocytic function in vitro stimulated by specific tumor polypeptide combined with dendritic cells [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1094-1098.
[5] Xin-yun YAO,Xiao-min GAO,Xiao-ying ZOU,Lin YUE. Role of endocytosis in cell surface CXC chemokine receptor 4 expression of stem cells from apical papilla [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 893-899.
[6] Jing XIE,Yu-ming ZHAO,Nan-quan RAO,Xiao-tong WANG,Teng-jiao-zi FANG,Xiao-xia LI,Yue ZHAI,Jing-zhi LI,Li-hong GE,Yuan-yuan WANG. Comparative study of differentiation potential of mesenchymal stem cells derived from orofacial system into vascular endothelial cells [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 900-906.
[7] SUN Jing, SONG Wei-dong, YAN Si-yuan, XI Zhi-jun. Chloroquine inhibits viability of renal carcinoma cells and enhances sunitinib-induced caspase-dependent apoptosis [J]. Journal of Peking University(Health Sciences), 2018, 50(5): 778-784.
[8] WANG Zi-cheng, CHENG Li, LV Tong-de, SU Li, LIN Jian, ZHOU Li-qun. Inflammatory priming adipose derived stem cells significantly inhibit the proliferation of peripheral blood mononuclear cells [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 590-594.
[9] TANG Xu, ZHAO Wei-hong, SONG Qin-qin, YIN Hua-qi, DU Yi-qing, SHENG Zheng-zuo, WANG Qiang, ZHANG Xiao-wei, LI Qing, LIU Shi-jun, XU Tao. Influence of SOX10 on the proliferation and invasion of prostate cancer cells [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 602-606.
[10] WANG Xiao-tong, RAO Nan-quan, FANG Teng-jiao-zi, ZHAO Yu-ming, GE Li-hong. Comparison of the properties of CD146 positive and CD146 negative subpopulations of stem cells from human exfoliated deciduous teeth [J]. Journal of Peking University(Health Sciences), 2018, 50(2): 284-292.
[11] CHEN Wei, HU Fan-lei, LIU Hong-jiang, XU Li-ling, LI Ying-ni, LI Zhan-guo. Myeloid-derived suppressor cells promoted autologous B cell proliferation in rheumatoid arthritis [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 819-823.
[12] CAI Yi, GUO Hao, LI Han-zhong, WANG Wen-da, ZHANG Yu-shi. MicroRNA differential expression profile in tuberous sclerosis complex cell line TSC2-/- MEFs and normal cell line TSC2+/+ MEFs [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 580-584.
[13] SIMA Zi-han, HONG Ying-ying, LI Tie-jun△. Effects of PTCH1 mutations on the epithelial proliferation derived from keratocystic odontogenic tumour [J]. Journal of Peking University(Health Sciences), 2017, 49(3): 522-526.
[14] GAO Xiang, CHEN Xiang-mei, ZHANG Ting, ZHANG Jing, CHEN Mo, GUO Zheng--yang, SHI Yan-yan, LU Feng-min, DING Shi-gang. Relationship between macrophage capping protein and gastric cancer cell’s proliferation and migration ability [J]. Journal of Peking University(Health Sciences), 2017, 49(3): 489-494.
[15] CAI Yuan-fa, ZHANG Hua-ming, NIU Wen-yi, ZOU Yong-qiu, MA De-fu. Effects of equol on colon cancer cell proliferation [J]. Journal of Peking University(Health Sciences), 2017, 49(3): 383-387.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd